Fonterra to appeal NSW Supreme Court decision on Bega Cheese
'Last week, the court stated it is unable to make a determination at this stage, as there is not yet enough certainty about the outcome of the divestment process.
'Our view has not changed as a result of the court decision and Fonterra intends to appeal this decision in the coming weeks,' Cronin said.
'This does not change our divestment plans, and we continue to pursue both a trade sale and initial public offering [IPO] as a potential divestment option.'
Last November, Fonterra filed proceedings to seek a determination of its rights regarding its licensing agreement with ASX-listed Bega.
Bega - backed by billionaire Andrew Forrest - is an Australian diversified food and drinks company with which Fonterra has long had a commercial relationship.
Bega itself has expressed a strong interest in picking up Fonterra's Oceania business, which has Anchor, Mainland, Perfect Italiano, Kapiti, Western Star, and Fresh'n Fruity brands, among others.
After last month's decision from the court, Bega said it was pleased with the outcome.
'Bega Group will always fight to protect its rights and we are very pleased with today's outcome,' executive chairman Barry Irvin said at the time.
'We hope to work constructively with Fonterra Group on the sale of its Oceania businesses, of which Bega Group is a natural acquirer and remains very interested in,' Irvin said.
Market expectations are for proceeds from the Mainland sale to be around $2.5 billion to $3b.
Australian media have reported private equity firms and strategic suitors have lodged bids for Mainland.
Bega and Lactalis - a French multinational dairy products company owned by the Besnier family - are understood to be contenders for Fonterra's consumer operations.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NZ Herald
3 hours ago
- NZ Herald
Global Dairy Trade auction sees prices dip 1.6%, whole milk powder down 3.7%
The new season opened with a 1.6% price drop across the board in the latest Global Dairy Trade auction. This follows a 0.9% dip from the previous auction, two weeks ago. Whole milk powder, which has the biggest impact on Fonterra's farmgate milk price, was down 3.7%, to an average
Scoop
a day ago
- Scoop
Pacific Edge Placement Upsized To NZ$16 Million
Press Release – Pacific Edge Pacific Edge is now targeting the opening of a NZ$5 million offer to eligible retail investors by way of a Share Purchase Plan (SPP) at the same NZ$0.10 cents per share offer price in July or early August 2025 (with the ability to accept oversubscriptions). Note: PEB has released this update to the NZX and ASX as per listing rules.1* Pacific Edge today announces it has successfully raised NZ$16 million of new equity in a placement of new ordinary shares (Placement) — NZ$1 million more than it sought — after Directors resolved to accept over subscriptions.2* The Placement, which was well supported by existing shareholders, was completed on Friday 30 May 2025 and is subject to shareholder approval.3* It was priced at NZ$0.10 cents per share, a premium to the 20-day volume average weighted price (VWAP) prior to the announcement of the company's planned ~NZ$20 million equity issue. Pacific Edge is now targeting the opening of a NZ$5 million offer to eligible retail investors by way of a Share Purchase Plan (SPP) at the same NZ$0.10 cents per share offer price in July or early August 2025 (with the ability to accept oversubscriptions).4 A shareholder meeting to approve the Placement is planned for late July or early August 2025. The Placement and the planned SPP are aimed at ensuring Pacific Edge has additional resources and capacity to capitalize on its recent clinical and commercial milestones, grow in non-Medicare channels and regain Medicare coverage of its tests. Medicare coverage of the company's tests ceased after the 'Genetic testing for Oncology; Specific Tests' (L39365) Local Coverage Determination became effective on 24 April 2025. Chairman Chris Gallaher said: 'We are delighted with the investor support we have received. The inclusion of Cxbladder in the American Urological Association's (AUA) new microhematuria guideline in February 2025 is significant and has allowed the company to view the non-coverage determination differently. We are leveraging the important AUA guideline to build on the commercial momentum we have already established, including our plans to regain Medicare coverage.' Pacific Edge Chief Executive Dr Peter Meintjes said: 'The robust evidence emerging from our clinical evidence program is shifting clinical sentiment towards the broader adoption of our tests in the US and further afield and represents a significant opportunity in addition to Medicare re-coverage. We are delighted with the strong support we have received from investors to continue to pursue our plans, and we are looking forward to making the same offer to the remainder of our shareholders via the SPP.' Pacific Edge is advised on the equity raise by Cameron Partners (investment banking advisers), Harmos Horton Lusk (legal advisers) and The Project (investor relations and communications advisers). For further information on the detail and timetable of the equity raising please refer to the announcement and presentation dated Thursday 29 May 2025 and released by NZX and ASX on Friday 30 May 2025. Footnote: 1* PEB has released the information contained in this update to the NZX and ASX as it regards it to be material, as defined in the NZX Listing Rules and Section 231 of the FMC Act. 2* Shareholder approval is required to settle the Placement (i.e., for payment for, and allotment of, the new shares offered under the Placement) given the Placement exceeds Pacific Edge's placement capacity (15% of Pacific Edge's current shares on issue) and due to Related Party participation. The Placement is also conditional on all necessary regulatory approvals. In this regard, the company intends to seek a waiver from NZX Listing Rule 4.19.1 to permit the allotment of shares under the Placement after shareholder approval is obtained. The Placement offer closed on 30 May 2025 for the purposes of clause 21(1)(b)(ii) of Schedule 8 to the Financial Markets Conduct Regulations 2014. 3* See footnote 1. 4* No offer of new shares is made under the SPP unless and until Pacific Edge sends the SPP offer document to shareholders. No money is currently being sought, and new shares cannot currently be applied for or acquired, under the SPP.
Techday NZ
a day ago
- Techday NZ
How businesses can close out FY24–25 on solid footing and start strong in FY25–26
Many Australian businesses are bracing for increased compliance scrutiny as the financial year draws to a close. The Australian Taxation Office (ATO) has flagged several key focus areas for FY24–25, including overdue tax debts, work-related expenses, capital gains, and rental income. Non-compliance in these areas can lead to substantial penalties, interest charges, and even legal action, as repeated late lodgements can result in increased fines, while unresolved tax debts could trigger garnishee notices or legal proceedings. This serves as a timely reminder to businesses of all sizes: take the end of the financial year (EOFY) seriously or risk facing serious consequences. Businesses with inconsistent record-keeping, unclear financial workflows, or unpaid obligations are more likely to attract attention. The ATO has invested in advanced data-matching tools and artificial intelligence (AI) to cross-check reported income and deductions against third-party sources, meaning even minor oversights can trigger audit activity or delays in processing. The most common pain points during EOFY tend to come down to two things: disorganised processes and incomplete information. It's easy to miss valid deductions when receipts are scattered across inboxes or stored on personal devices as manual reconciliation can take days for lean financial teams. Payments to suppliers can also slip through the cracks when approval workflows are unclear or not followed consistently. These issues might seem minor in isolation; however, they often reflect deeper structural problems in how expenses and invoices are managed. Now is the time to close those gaps. Businesses should start by gathering complete records for income, expenses, assets, and liabilities. Finance personnel need to go beyond general ledgers and profit-and-loss statements, and carefully review reimbursement claims, subscription costs, software expenses, and travel records. The next step is to consolidate the data to get a single, accurate view of payments, especially if the business has used multiple systems to process payments or expenses. It's important to also check whether claims align with ATO expectations. For example, the ATO has emphasised again that work-from-home deductions must reflect actual usage, not estimates. It also continues to highlight common errors in rental income reporting and capital gains declarations. These areas are under close watch, and discrepancies are harder to defend when documentation is patchy. Compliance is only one part of the EOFY picture. Cybercriminals target finance teams with tax-themed scams at this time of year. According to the Australian Competition and Consumer Commission (ACCC), Australians lost more than $152 million to payment redirection scams in 2024, up from $91.6 million the previous year, making it one of the top five scam types by financial loss. This highlights the need for tighter controls. Business leaders must review who has approval access, how and where sensitive documents are stored, and the process used to verify vendor details. It's also critical to validate that everyone involved in payments or account management understands these risks and are trained to spot suspicious activity. Businesses that want to reduce risk and simplify EOFY reporting can make immediate gains by automating expense and invoice management. Automation tools reduce reliance on spreadsheets and email chains while applying consistent rules and approval flows simultaneously, which helps teams process claims faster and with fewer errors. This gives businesses of all sizes clearer visibility into spending and more accurate data for compliance reporting and strategic planning. Businesses can shift their focus to FY25–26 ahead once EOFY obligations are complete. Notably, e-invoicing will become mandatory for all Commonwealth agencies and their suppliers from 1 July 2025. Adopting this early can help businesses reduce processing times, cut operating costs, and improve cash flow. The start of the financial year is the ideal time to step back and assess what's working and what needs improvement. Delays in approvals, hard-to-produce reports, or unclear spending are signs of deeper process issues. Now's the time to fix them. EOFY is an opportunity for businesses of all sizes to improve how they manage spending, reporting, and decision-making. Those that invest in better systems now will be better positioned to grow in the year ahead.
